|
|||
|
Multiple Sclerosis Info
|
Monday, February 4
FDA Approves Betaseron for Use After the First Event Suggestive of Multiple Sclerosis
by
All About MS
on Mon 04 Feb 2008 07:20 AM CST
The two-year study showed that treatment with Betaseron delayed the time to a second clinical event by one year compared to placebo. (1) BENEFIT is the only trial to demonstrate the more »
|
||
